Southern Acids (malaysia) Bhd. · MYX:SAB

Southern Acids (malaysia) Bhd — Southern Acids (M) Berhad — Shareholder Meeting (August 2024)

15 slides from Southern Acids (malaysia) Bhd's shareholder meeting presentation, Aug 26, 2024

  1. Slide 1: Southern Acids (M) Berhad 43rd Annual General Meeting

    SOUTHERN ACIDS (M) BERHAD 43rd ANNUAL GENERAL MEETING 26 AUGUST 2024 SHAREHOLDERS BRIEFING

  2. Slide 2: Source of Information & Disclaimer

    SLIDE 1 SOURCE OF INFORMATION & DISCLAIMER Source of Information Used For The Presentation  The Company’s 2024 Annual Report; and  All other information that are available from Bursa Malaysia Securities Berhad’s website. Disclaimer Information contained in this presentation is intended solely for

  3. Slide 3: Content

    SLIDE 2 CONTENT 1. Southern Acids (M) Berhad (“SAB or the Company”) & Its Subsidiaries a. SAB & Its Subsidiaries Key Financial Highlights For The Financial Year Ended 31 March 2024 (“FY2024) 2. The Respective Segments a. Review Of The Respective Segments’ Financial Performance b. Respective Segments

  4. Slide 4: SAB & Its Subsidiaries Key Financial Performance for FY2024

    SOUTHERN ACIDS (M) BERHAD SAB & ITS SUBSIDIARIES KEY FINANCIAL PERFORMANCE FOR FY2024

  5. Slide 5: SAB & Its Subsidiaries' Financial Performance

    SLIDE 3 SAB & ITS SUBSIDIARIES’ FINANCIAL PERFORMANCE FY2024 FY2023 Changes Changes RM’000 RM’000 RM’000 % Consolidated Revenue 907,963 1,099,875 (191,912) (17.4%) Consolidated Profit Before Tax 43,166 74,909 (31,743) (42.4%) (“PBT”) /(Loss Before Tax)(“LBT”) Segment’s PBT/(LBT) Oleochemical Manufac

  6. Slide 6: SAB & Its Subsidiaries' Key Financial Highlights

    SLIDE 4 SAB & ITS SUBSIDIARIES’ KEY FINANCIAL HIGHLIGHTS FY2024 FY2023 Changes RM’000 RM’000 RM’000 % Consolidated Profit After Tax And 13,634 33,292 (19,658) (59.0%) Minority Interest Shareholders’ Equity 779,570 754,927 24,643 3.3% RM RM RM % Net Asset Per Share 5.69 5.51 0.18 3.3% Earnings Per Sh

  7. Slide 7: Review of the Respective Segments' Financial Performance

    SOUTHERN ACIDS (M) BERHAD REVIEW OF THE RESPECTIVE SEGMENTS’ FINANCIAL PERFORMANCE

  8. Slide 8: Oleochemical Manufacturing Financial Performance

    SLIDE 5 OLEOCHEMICAL MANUFACTURING FINANCIAL PERFORMANCE FY2024 FY2023 Changes Changes RM’000 RM’000 RM’000 % Revenue 356,142 478,996 (122,854) (25.6%) PBT/(LBT) Core PBT/(LBT) (37,576) (27,777) (9,799) (35.3%) Non-Core PBT 4,931 628 4,303 > 100.0% (32,645) (27,149) (5,496) (20.2%)

  9. Slide 9: Oleochemical Manufacturing Outlook for FY2025

    SLIDE 6 OLEOCHEMICAL MANUFACTURING OUTLOOK FOR FY2025 Challenging, key factors are as follows: 1. External factors;  Highly competitive global market;  USD/MYR exchange rate; and  Volatility of commodity prices. 1. Internal factors;  Rising production costs; and  Increasing trend of regulated i

  10. Slide 10: Milling & Cultivation Financial Performance

    SLIDE 7 MILLING & CULTIVATION FINANCIAL PERFORMANCE FY2024 FY2023 Changes Changes RM’000 RM’000 RM’000 % Revenue 413,259 484,796 (71,537) (14.8%) PBT Core PBT 16,428 52,404 (35,976) (68.7%) Non-Core PBT 32,499 22,148 10,351 46.7% 48,927 74,552 (25,625) (34.4%)

  11. Slide 11: Milling & Cultivation Outlook for FY2025

    SLIDE 8 MILLING & CULTIVATION OUTLOOK FOR FY2025 Challenging, the performance of Milling & Cultivation is largely subjected to the following uncontrollable factors:-  Commodity prices;  Availability of fresh fruit bunches, externally and internally;  Higher production costs such as labour, fertil

  12. Slide 12: Healthcare Services Financial Performance

    SLIDE 9 HEALTHCARE SERVICES FINANCIAL PERFORMAMCE FY2024 FY2023 Changes Changes RM’000 RM’000 RM’000 % Revenue 117,959 112,727 5,232 4.6% PBT Core PBT 32,361 28,808 3,553 12.3% Non-Core PBT 3,370 2,612 758 29.0% 35,731 31,420 4,311 13.7%

  13. Slide 13: Healthcare Services Outlook for FY2025

    SLIDE 10 HEALTHCARE SERVICES OUTLOOK FOR FY2025 Continue stable growth  Continue to improve our service levels as follow:- o High quality healthcare services o Enhance medical facilities; and o Strengthening the team of medical professionals

  14. Slide 14: SAB Group Outlook for FY2025

    SLIDE 11 SAB GROUP OUTLOOK FOR FY2025 We remain cautious, the concern over global market uncertainty and ongoing geopolitical tensions are significant factors that will challenge our businesses.

  15. Slide 15: Thank You, Questions & Answers

    SOUTHERN ACIDS (M) BERHAD THANK YOU QUESTIONS & ANSWERS

Southern Acids (M) Berhad — Shareholder Meeting (August 2024) on 6ix